The management of the clinically positive neck as part of a larynx preservation approach
- PMID: 8344843
- DOI: 10.1016/0360-3016(93)90489-i
The management of the clinically positive neck as part of a larynx preservation approach
Abstract
Purpose: For patients with squamous cell carcinoma of the head and neck with palpable neck node metastases, the standard management of the neck usually involves neck dissection and postoperative neck irradiation. A strategy of larynx preservation with induction chemotherapy and radiation therapy has been utilized for patients with locally advanced resectable cancer of the larynx, hypopharynx, and oropharynx. For patients treated in this non-surgical manner for the primary site, the optimal management of the clinically positive neck has not been clarified. To determine whether response to induction chemotherapy could help to select patients in whom neck dissection could be omitted in favor of definitive radiation therapy alone, we have analyzed our prospective larynx preservation experience.
Method and materials: Between 1983-1989, 80 patients were entered onto larynx preservation protocols involving 1-3 cycles of cisplatin based chemotherapy followed by radiation therapy with or without neck dissection. There were 54 patients with clinically positive necks to treatment, of whom 44% (24/54) had a complete response, and of whom 20% (11/54) had a partial response to chemotherapy in the neck. In 22 of these 35 patients with clinically positive necks who achieved a major neck response to chemotherapy, radiation therapy (median 66 Gy) was used as the only subsequent treatment of the neck.
Results: At a median follow-up of 25 months (range 7-83 months), neck control for this subset is 91% (20/22). Neck failure occurred in 20% (1/5) of patients with a partial response to chemotherapy treated without neck dissection and 6% (1/17) of node positive with a complete response.
Conclusion: These results suggest that patients with clinically palpable cervical nodal metastases who have a complete response to chemotherapy and receive high dose radiation therapy have excellent neck control and may not need neck dissection. Further experience will be required to confirm these preliminary data and to determine if patients who achieve a partial response in the neck after induction chemotherapy can be treated with radiation therapy without neck dissection.
Similar articles
-
Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.J Clin Oncol. 1994 May;12(5):946-53. doi: 10.1200/JCO.1994.12.5.946. J Clin Oncol. 1994. PMID: 8164046 Clinical Trial.
-
Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy.Laryngoscope. 1997 Aug;107(8):1129-37. doi: 10.1097/00005537-199708000-00023. Laryngoscope. 1997. PMID: 9261021
-
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.J Natl Cancer Inst. 1996 Jul 3;88(13):890-9. doi: 10.1093/jnci/88.13.890. J Natl Cancer Inst. 1996. PMID: 8656441 Clinical Trial.
-
Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer.Semin Surg Oncol. 1993 Jan-Feb;9(1):3-13. doi: 10.1002/ssu.2980090103. Semin Surg Oncol. 1993. PMID: 8356382 Review.
-
[Chemotherapy of head and neck cancer].Gan To Kagaku Ryoho. 1996 Feb;23(3):277-82. Gan To Kagaku Ryoho. 1996. PMID: 8712819 Review. Japanese.
Cited by
-
Management of the Neck after Treatment with Radiation with or without Chemotherapy.Curr Treat Options Oncol. 2007 Jun;8(3):261-4. doi: 10.1007/s11864-007-0029-x. Curr Treat Options Oncol. 2007. PMID: 17713722 Review. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical